Eden Research plc
EDNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $4 | $3 | $2 | $1 |
| % Growth | 34.8% | 74.7% | 48.7% | – |
| Cost of Goods Sold | $2 | $1 | $2 | $1 |
| Gross Profit | $2 | $2 | $0 | $0 |
| % Margin | 43.5% | 55.3% | 11.3% | 2.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4 | $3 | $3 | $3 |
| SG&A Expenses | $4 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Expenses | $4 | $4 | $3 | $3 |
| Operating Income | -$2 | -$2 | -$3 | -$3 |
| % Margin | -50.8% | -58.5% | -140.5% | -261.1% |
| Other Income/Exp. Net | $0 | -$5 | -$0 | -$0 |
| Pre-Tax Income | -$2 | -$7 | -$3 | -$3 |
| Tax Expense | -$0 | -$0 | -$0 | -$1 |
| Net Income | -$2 | -$6 | -$2 | -$3 |
| % Margin | -44.3% | -203.5% | -122.4% | -227% |
| EPS | -0.004 | -0.015 | -0.006 | -0.007 |
| % Growth | 76.6% | -161% | 19.2% | – |
| EPS Diluted | -0.004 | -0.015 | -0.006 | -0.007 |
| Weighted Avg Shares Out | 533 | 421 | 381 | 380 |
| Weighted Avg Shares Out Dil | 533 | 421 | 381 | 380 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$2 | -$6 | -$2 | -$3 |
| % Margin | -36.9% | -195.6% | -101.7% | -221% |